NCT04638283

The Efficacy of Goal Focused, Non-Pharmacological Treatment for Persons With ADHD/ADD.

Completed NA Last updated 18 February 2022

What this trial tests

NA trial testing Goal Attainment Scaling in Attention-Deficit Hyperactivity Disorder, Unspecified Type in 80 participants. Completed in 1 February 2022.

Timeline

15 August 2019

Primary endpoint
1 February 2022

1 February 2022

Quick facts

Lead sponsor	University Hospital, Akershus
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	80
Start date	15 August 2019
Primary completion	1 February 2022
Estimated completion	1 February 2022
Sites	1 location across Norway

Drugs / interventions tested

• Goal Attainment Scaling

Conditions studied

• Attention-Deficit Hyperactivity Disorder, Unspecified Type — all drugs for Attention-Deficit Hyperactivity Disorder, Unspecified Type →

Sponsor

University Hospital, Akershus

Who can join

Adults 18 to 60, any sex, with Attention-Deficit Hyperactivity Disorder, Unspecified Type. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to improve the understanding of non-pharmacological treatments of ADHD with a particular emphasis on coping with executive problems. Executive functions can be defined as those abilities necessary to formulate goals, carry them out effectively and enabling a person to engage successfully in independent, purposive, self-serving behavior.

The intervention consists of:

1. Eight psycho-educative group sessions focusing on Goal Management Training (GMT), a method aiming to enhance goal directed behavior, developed by Levine and colleagues in 2011.
2. Four individual sessions where the participants are guided through the process of formulation individual goals for improving functioning in everyday life. The method used for goal setting is Goal Attainment Scaling (GAS), developed by Kiresuk and Sherman in 1968.
3. Bi-weekly telephone follow up the first three months preceding the group sessions, focusing on the attainment of GAS-goals.

Adult participants with ADHD/ADD are recruited from the outpatient psychiatric health care clinic, DPS Nedre Romerike at Akershus University Hospital and are randomized into either 1) an intervention-group, receiving the intervention described above or 2) a control-group receiving treatment as usual.

It is hypothesized that the intervention will improve executive functioning, reported ADHD-symptoms and psychological well-being. It is also hypothesized that the participants sucessfully will formulate and implement GAS-goals and that goal attainment will sustain throughout the follow-up phase.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Improvement of anxiety in ADHD following goal-focused cognitive remediation: a randomized controlled trial.
   Hanssen KT, Brevik EJ, Småstuen MC, Stubberud J. · · 2023 · cited 5× · PMID 38046113 · DOI 10.3389/fpsyg.2023.1212502